Physician

Dan Ang Gong, M.D.

According to 2025 Medicare claims, Dan Gong, M.D. (NPI: 1346621596) practices ophthalmology in the Providence-Warwick, RI-MA market, with the plurality of this provider's patient population coming from Bristol, MA. This provider's primary affiliated billing organization is MASSACHUSETTS EYE AND EAR ASSOCIATES, INC. (NPI: 1598160095) and primary practice location at 02904-2773. Gong is affiliated with the Mass General Brigham ACO, LLC (ACO ID: A4641), participating under the MSSP model.

Gong's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 835 traditional Medicare patients, billed 6,242 HCPCS/CPT codes, and received $542,625 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 651 prescription claims across 149 beneficiaries totaling $38,143 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). 2016 DME data shows 11 claims. Open Payments data shows 3 records totaling $327. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $7,002 to $542,625. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $3,935 and ending at $38,143. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	41	63	$7,002
2020	109	166	$17,112
2021	447	1,436	$118,507
2022	711	3,768	$327,010
2023	681	4,177	$394,335
2024	835	6,242	$542,625

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	12	34	$3,935
2016	68	283	$38,488
2017	182	1,038	$51,940
2018	162	818	$40,520
2019	248	1,392	$80,784
2020	202	642	$35,793
2021	124	356	$17,603
2022	107	536	$27,814
2023	109	436	$26,425
2024	149	651	$38,143

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	11	$917
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
67028	Injection of drug into eye	260	1,041	$80
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	148	189	$73
92014	Established patient complete exam of visual system	473	617	$59
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	102	171	$54
92134	Imaging of retina	827	2,043	$21

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	169	5,867	$5,482
Bromfenac Sodium	Bromfenac Sodium	24	662	$5,163
Difluprednate	Difluprednate	75	1,566	$4,988
Ketorolac Tromethamine	Ketorolac Tromethamine	122	4,005	$2,015
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	43	2,765	$836

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$327	Genentech USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Dan Ang Gong, M.D.?

Tedicare shows public-source Medicare data for Dan Ang Gong, M.D. (NPI 1346621596), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Dan Ang Gong, M.D. have ACO affiliation data?

Dan Ang Gong, M.D. is shown with ACO affiliation data for Mass General Brigham ACO, LLC (MSSP, ACO ID A4641).

What billing organization is linked to Dan Ang Gong, M.D.?

Dan Ang Gong, M.D. is linked to MASSACHUSETTS EYE AND EAR ASSOCIATES, INC. (billing NPI 1598160095) in the available physician profile data.

Does Dan Ang Gong, M.D. have Open Payments data?

Dan Ang Gong, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.